Circulating tumour cells in prostate cancer patients receiving salvage radiotherapy
- 17 February 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical and Translational Oncology
- Vol. 14 (2), 150-156
- https://doi.org/10.1007/s12094-012-0775-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate CancerClinical Cancer Research, 2008
- Salvage radiotherapy following radical prostatectomyInternational Journal of Urology, 2008
- Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2008
- Circulating Tumor Cells in Peripheral Blood Samples From Patients With Increased Serum Prostate Specific Antigen: Initial Results in Early Prostate CancerJournal of Urology, 2008
- Prostate-specific antigen and prostate cancer: prediction, detection and monitoringNature Reviews Cancer, 2008
- FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcomeBritish Journal of Cancer, 2007
- Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical ProstatectomyJournal of Clinical Oncology, 2007
- TMPRSS2:ETV4 Gene Fusions Define a Third Molecular Subtype of Prostate CancerCancer Research, 2006
- Salvage radiation for a rising PSA following radical prostatectomyUrologic Oncology, 2004
- Can Radical Prostatectomy Alter the Progression of Poorly Differentiated Prostate Cancer?Journal of Urology, 1994